Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia B Mattis

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Brain Research|October 14, 2015
Modeling Huntington׳s disease with patient-derived neuronsVirginia B Mattis, Clive N Svendsen
The Lancet. Neurology|March 26, 2011
Induced pluripotent stem cells: a new revolution for clinical neurology?Virginia B Mattis, Clive N Svendsen
Nature Neuroscience|February 25, 2018
Huntington modeling improves with ageVirginia B Mattis, Clive N Svendsen
Drug News & Perspectives|October 30, 2010
Therapeutics that directly increase SMN expression to treat spinal muscular atrophyMonir Shababi, Virginia B Mattis, Christian L Lorson
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2018
Cellular Models: HD Patient-Derived Pluripotent Stem CellsCharlene Geater, Sarah Hernandez, Leslie Thompson, et al.
Journal of Neuroscience Methods|September 6, 2008
Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophyVirginia B Mattis, Matthew E R Butchbach, Christian L Lorson
Neuroscience Letters|July 24, 2012
Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophyVirginia B Mattis, Cheng-Wei Tom Chang, Christian L Lorson
Neuroscience Letters|July 8, 2008
A SMNDelta7 read-through product confers functionality to the SMNDelta7 proteinVirginia B Mattis, Melissa Bowerman, Rashmi Kothary, et al.
Frontiers in Neuroscience|October 26, 2017
Optimization of <i>trans</i>-Splicing for Huntington's Disease RNA TherapyHansjörg Rindt, Colton M Tom, Christian L Lorson, et al.
Human Molecular Genetics|December 17, 2008
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophyFerrill F Rose, Virginia B Mattis, Hansjörg Rindt, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Brain Research|October 14, 2015
Modeling Huntington׳s disease with patient-derived neuronsVirginia B Mattis, Clive N Svendsen
The Lancet. Neurology|March 26, 2011
Induced pluripotent stem cells: a new revolution for clinical neurology?Virginia B Mattis, Clive N Svendsen
Nature Neuroscience|February 25, 2018
Huntington modeling improves with ageVirginia B Mattis, Clive N Svendsen
Drug News & Perspectives|October 30, 2010
Therapeutics that directly increase SMN expression to treat spinal muscular atrophyMonir Shababi, Virginia B Mattis, Christian L Lorson
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2018
Cellular Models: HD Patient-Derived Pluripotent Stem CellsCharlene Geater, Sarah Hernandez, Leslie Thompson, et al.
Journal of Neuroscience Methods|September 6, 2008
Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophyVirginia B Mattis, Matthew E R Butchbach, Christian L Lorson
Neuroscience Letters|July 24, 2012
Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophyVirginia B Mattis, Cheng-Wei Tom Chang, Christian L Lorson
Neuroscience Letters|July 8, 2008
A SMNDelta7 read-through product confers functionality to the SMNDelta7 proteinVirginia B Mattis, Melissa Bowerman, Rashmi Kothary, et al.
Frontiers in Neuroscience|October 26, 2017
Optimization of <i>trans</i>-Splicing for Huntington's Disease RNA TherapyHansjörg Rindt, Colton M Tom, Christian L Lorson, et al.
Human Molecular Genetics|December 17, 2008
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophyFerrill F Rose, Virginia B Mattis, Hansjörg Rindt, et al.
Pageof 3